These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20715976)

  • 41. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
    Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
    In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans.
    Enkhmaa B; Anuurad E; Zhang Z; Pearson TA; Berglund L
    Am J Cardiol; 2010 Nov; 106(9):1264-9. PubMed ID: 21029822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.
    Sapkota B; Subramanian A; Priamvada G; Finely H; Blackett PR; Aston CE; Sanghera DK
    J Diabetes Complications; 2015; 29(8):1191-7. PubMed ID: 26318958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. APOE genotype-function relationship: evidence of -491 A/T promoter polymorphism modifying transcription control but not type 2 diabetes risk.
    Geng H; Law PP; Ng MC; Li T; Liang LY; Ge TF; Wong KB; Liang C; Ma RC; So WY; Chan JC; Ho YY
    PLoS One; 2011; 6(10):e24669. PubMed ID: 22028770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
    Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ
    J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of apolipoprotein E gene polymorphism and Lp(a) levels on coronary artery disease with atrial fibrillation.
    Li Y; Chen L; Shao Y; Zhang M; Zhi L; Lu Y
    J Int Med Res; 2022 Jul; 50(7):3000605221109387. PubMed ID: 35850541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
    Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study.
    Corsetti JP; Gansevoort RT; Bakker SJL; Dullaart RPF
    J Clin Lipidol; 2016; 10(4):842-850. PubMed ID: 27578115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein E polymorphism and renal disease.
    Oda H; Yorioka N; Ueda C; Kushihata S; Yamakido M
    Kidney Int Suppl; 1999 Jul; 71():S25-7. PubMed ID: 10412731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease].
    Zhu T; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease.
    Wu L; Zhang Y; Zhao H; Rong G; Huang P; Wang F; Xu T
    Front Endocrinol (Lausanne); 2022; 13():838547. PubMed ID: 35211094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass.
    Grünenfelder J; Umbehr M; Plass A; Bestmann L; Maly FE; Zünd G; Turina M
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):92-7. PubMed ID: 15224026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atheromatosis extent in coronary artery disease is not correlated with apolipoprotein-E polymorphism and its plasma levels, but associated with cognitive decline.
    Lima LM; Carvalho Md; Ferreira CN; Fernandes AP; Neto CP; Garcia JC; Reis HJ; Janka Z; Palotás A; Sousa Md
    Curr Alzheimer Res; 2010 Sep; 7(6):556-63. PubMed ID: 20455863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics.
    Dlouha L; Pelikanova T; Veleba J; Adamkova V; Lanska V; Sosna T; Pacal L; Kankova K; Hubacek JA
    Mol Biol Rep; 2021 Aug; 48(8):5873-5879. PubMed ID: 34328600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study.
    Tiret L; de Knijff P; Menzel HJ; Ehnholm C; Nicaud V; Havekes LM
    Arterioscler Thromb; 1994 Oct; 14(10):1617-24. PubMed ID: 7918312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Distribution of Apolipoprotein E Gene Polymorphism and Apolipoprotein E Levels among Coronary Artery Patients Compared to Controls.
    Atis O; Sahin S; Ceyhan K; Ozyurt H; Akbas A; Benli I
    Eurasian J Med; 2016 Jun; 48(2):90-4. PubMed ID: 27551170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.